Adipose-derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome
Status:
Unknown status
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Currently, there is no proven effective pharmacologic treatment available for patients with
the acute respiratory distress syndrome (ARDS). Mesenchymal stem cells have been shown to be
effective in treating several inflammatory diseases. The main purpose of this study is to
assess the safety of allogeneic adipose-derived mesenchymal stem cells in patients with ARDS.